3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
6
Unknown
2
Recruiting
2
Active not recruiting
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
10
Gastrointestinal
6
Thoracic
4
Lymphoid
3
Other
2
Plasma cell
1
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Classical hematology
1
CNS
1
Conditions
Obesity
60
Neoplasms
20
Overweight
17
Polycystic Ovary Syndrome
11
Dyspnea
10
Sexual Dysfunction, Physiological
9
Prostatic Neoplasms
7
Motor Activity
7
Hypertension
7
Endometrial Neoplasms
7
Breast Neoplasms
7
Diabetes Mellitus, Type 2
6
Mucositis
5
Metabolic Syndrome
5
Diabetes Mellitus
5
Pulmonary Disease, Chronic Obstructive
4
Lung Neoplasms
4
Depression
4
Constipation
4
Cardiovascular Diseases
4
Weight Loss
3
Stomatitis
3
Renal Insufficiency, Chronic
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Opioid-Induced Constipation
3
Non-alcoholic Fatty Liver Disease
3
Myasthenia Gravis
3
Insulin Resistance
3
Heart Failure
3
Endometrial Hyperplasia
3
Interventions
Tablets
1
Specimen Handling
1
Pregabalin
1
Omeprazole
1
Ketorolac
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Inflammation
×
Other
×
Clear all
NCT07189806
2025-09-24
MAPLE-UK
Hvivo
Recruiting
250 enrolled
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled